Cargando…

5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales: Pastore, Serena, Stocco, Gabriele, Moressa, Valentina, Sandrin, Chiara, Decorti, Giuliana, Lepore, Loredana, Taddio, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184166/
http://dx.doi.org/10.1186/1546-0096-12-S1-P10
_version_ 1782337799900364800
author Pastore, Serena
Stocco, Gabriele
Moressa, Valentina
Sandrin, Chiara
Decorti, Giuliana
Lepore, Loredana
Taddio, Andrea
author_facet Pastore, Serena
Stocco, Gabriele
Moressa, Valentina
Sandrin, Chiara
Decorti, Giuliana
Lepore, Loredana
Taddio, Andrea
author_sort Pastore, Serena
collection PubMed
description
format Online
Article
Text
id pubmed-4184166
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41841662014-10-30 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis Pastore, Serena Stocco, Gabriele Moressa, Valentina Sandrin, Chiara Decorti, Giuliana Lepore, Loredana Taddio, Andrea Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4184166/ http://dx.doi.org/10.1186/1546-0096-12-S1-P10 Text en Copyright © 2014 Pastore et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Pastore, Serena
Stocco, Gabriele
Moressa, Valentina
Sandrin, Chiara
Decorti, Giuliana
Lepore, Loredana
Taddio, Andrea
5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
title 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
title_full 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
title_fullStr 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
title_full_unstemmed 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
title_short 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
title_sort 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184166/
http://dx.doi.org/10.1186/1546-0096-12-S1-P10
work_keys_str_mv AT pastoreserena 5aminoimidazole4carboxamideribonucleotidetransformylaseandinosinetriphosphatepyrophosphatasegenesvariantspredictremissionrateduringmethotrexatetherapyinpatientswithjuvenileidiopathicarthritis
AT stoccogabriele 5aminoimidazole4carboxamideribonucleotidetransformylaseandinosinetriphosphatepyrophosphatasegenesvariantspredictremissionrateduringmethotrexatetherapyinpatientswithjuvenileidiopathicarthritis
AT moressavalentina 5aminoimidazole4carboxamideribonucleotidetransformylaseandinosinetriphosphatepyrophosphatasegenesvariantspredictremissionrateduringmethotrexatetherapyinpatientswithjuvenileidiopathicarthritis
AT sandrinchiara 5aminoimidazole4carboxamideribonucleotidetransformylaseandinosinetriphosphatepyrophosphatasegenesvariantspredictremissionrateduringmethotrexatetherapyinpatientswithjuvenileidiopathicarthritis
AT decortigiuliana 5aminoimidazole4carboxamideribonucleotidetransformylaseandinosinetriphosphatepyrophosphatasegenesvariantspredictremissionrateduringmethotrexatetherapyinpatientswithjuvenileidiopathicarthritis
AT leporeloredana 5aminoimidazole4carboxamideribonucleotidetransformylaseandinosinetriphosphatepyrophosphatasegenesvariantspredictremissionrateduringmethotrexatetherapyinpatientswithjuvenileidiopathicarthritis
AT taddioandrea 5aminoimidazole4carboxamideribonucleotidetransformylaseandinosinetriphosphatepyrophosphatasegenesvariantspredictremissionrateduringmethotrexatetherapyinpatientswithjuvenileidiopathicarthritis